This session will review how S1P inhibitors work, what we need to know clinically to use them, and what we can expect in terms of response. This session is supported by an independent educational grant from Bristol Myers Squibb.
Learning Objectives:
Summarize key efficacy and safety data for new and emerging S1P receptor modulators in the treatment of IBD
Leverage the benefits of S1P receptor modulator treatment in appropriate patients with UC